pharmacotherapy Update : pregabalin in the Treatment of Generalized Anxiety Disorder

@inproceedings{Montgomery2010pharmacotherapyU,
  title={pharmacotherapy Update : pregabalin in the Treatment of Generalized Anxiety Disorder},
  author={Stuart A. Montgomery and Siegfried Kasper},
  year={2010}
}
Generalized anxiety disorder (GAD) is a common disorder that is chronic, disabling, and often goes undiagnosed. Currently, four distinct classes of medications have demonstrated efficacy in the treatment of GAD: benzodiazepines, serotonin and/or norepinephrine reuptake inhibitors (SSRIs/SNRIs), histamine H1 receptor blockers (hydroxyzine), and pregabalin. Pregabalin acts via binding to an α2-δ subunit presynaptic membrane protein that inhibits neurotransmitter release in excited neurons… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 64 references

Comparison of sleep outcomes in generalized anxiety disorder following treatment with pregabalin or venlafaxineXR

AV Joshi, FS Mandel, E Schweizer, BK Herman
Poster presentation at the 162 nd annual meeting of the American Psychiatric Association in San Francisco • 2009

Efficacy and tolerability of pregabalin in patients with generalized anxiety disorder in everyday clinical practice

HJ Möller, M Brasser, S Kasper, HP Volz, B Bandelow
Poster presentation at the 18 th annual European Psychiatric Association Meeting in Lisbon January • 2009

Similar Papers

Loading similar papers…